Baudax Bio, Inc.
BXRXQ
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -1.93M | -7.38M | 11.40M | -9.25M | -29.21M |
| Total Depreciation and Amortization | 131.00K | 1.00K | 3.00K | 40.00K | 9.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | 65.00K | -- |
| Total Other Non-Cash Items | -3.44M | 2.55M | -16.12M | 5.96M | 24.64M |
| Change in Net Operating Assets | 2.83M | 654.00K | 777.00K | -594.00K | 669.00K |
| Cash from Operations | -2.41M | -4.17M | -3.94M | -3.78M | -3.89M |
| Capital Expenditure | -21.00K | -- | -- | 0.00 | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 142.00K | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -21.00K | 142.00K | -- | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -550.00K | -2.40M | -1.10M | -1.13M | -834.00K |
| Issuance of Common Stock | 2.03M | 3.49M | 4.33M | 4.73M | 5.36M |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -94.00K | -177.00K | -20.00K | -205.00K | -200.00K |
| Cash from Financing | 1.38M | 917.00K | 3.21M | 3.40M | 4.33M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 726.00K | -726.00K | -- | -- |
| Net Change in Cash | -1.05M | -2.39M | -1.46M | -388.00K | 437.00K |